Market Cap 89.89M
Revenue (ttm) 0.00
Net Income (ttm) -24.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.30
Volume 55,500
Avg Vol 527,138
Day's Range N/A - N/A
Shares Out 84.80M
Stochastic %K 44%
Beta 3.09
Analysts Strong Sell
Price Target $6.00

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 908 967 6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
TwongStocks
TwongStocks Feb. 3 at 3:51 PM
$CTOR New hire. Chad Lachapelle. Head of Sales at CTOR. He was originally hired by $CTXR in April 2024 to be the Head of Sales. But he left in June 2025 to join YMAB. Looks like he is back with CTOR.
0 · Reply
TwongStocks
TwongStocks Feb. 2 at 3:21 PM
Fiscal Q1 for $CTXR and $CTOR ended on Dec 31. 10-Q filing deadline is Monday Feb 16. Both CTXR and CTOR will have to file their respective 10-Qs within the next couple of weeks. Biggest item is Lymphir sales. CTOR reported that it launched in December. The upcoming 10-Q will report Lymphir's sales from launch through Dec 31. First full quarter of Lymphir sales (Jan-Mar 2026) will not be reported until the May 10-Q. Other items to look for: • Cash on hand as of Dec 31 and updated runway for both companies. In the Dec 10-K, both companies reported a runway through March 2026. • Will there be any updates on Mino-Lok or Halo-Lido? • Will they issue any 2026 guidance for Lymphir sales?
5 · Reply
TwongStocks
TwongStocks Jan. 29 at 10:01 PM
$CTOR Definitive notice of shareholder consent filed. https://www.sec.gov/Archives/edgar/data/1851484/000121390026009524/ea0274187-def14c_citius.htm No major changes to the preliminary filing from Jan 20, which is explained in the quoted post. The approval of the warrants becomes effective February 18.
0 · Reply
kman1
kman1 Jan. 29 at 8:22 PM
$CTOR strange as he'll. Stock is running and no one says anything. This is rare as hens teeth.
0 · Reply
SweStonk
SweStonk Jan. 28 at 3:20 PM
$CTOR would be interesting to know how many over at $CTXR after being down 98%, bought Mazurs crap once again and invested in CTOR And if you did, how much are you down in CTOR? 50%?, 70%? Only one making money from CTXR and CTOR are Mazur and the shorts who are paying him heavily straight to his cayman account. Pssst, I have $5M to donate to charity but I dont have $5M or less to double down on the 98% loss on my 1 billion drug. Even tho you try to sell this shit to others? We all know if the pipeline was as you say it is you would have added on your position in a heart beat. But you and no one else in the management are and havent for YEARS because you know the scam will eventually crack...
1 · Reply
whathappenedtomyaccount
whathappenedtomyaccount Jan. 27 at 3:47 PM
$CTOR didn't they say they had manufactured stock on the shelves? what's the shelf life of that? is it just going to waste?
0 · Reply
SweStonk
SweStonk Jan. 23 at 10:49 PM
$CTOR You clearly dont know how to read. Argumenting with you is like talking to a wall. Go read business update from CTXR(parent company) and you will see they need more funding to commercialize lymphir and why Mazur is getting sued over his launch PR and later change to needing additional funding to commercialize. This is from the companies own business update. You should go read up before even thinking of making comments on a stock forum. You have facebook for the other stuff.... ML = dead Halo = dead Lymphir = not enough money and third in line treatment with better treatments making less than 100m/y(Lymphir with the debt = dead)
0 · Reply
NYC100
NYC100 Jan. 23 at 10:38 PM
$CTOR you getting mad because of the truth 😂😂
1 · Reply
SweStonk
SweStonk Jan. 23 at 10:27 PM
$CTOR People like him is why Mazur can continue his scam. News headline is enough of DD to invest into a company... You should just hand me your money. Your portfolio will be gone within a year anyway.
0 · Reply
NYC100
NYC100 Jan. 23 at 10:08 PM
$CTOR in the market and making money 💰 😂😂
1 · Reply
Latest News on CTOR
TwongStocks
TwongStocks Feb. 3 at 3:51 PM
$CTOR New hire. Chad Lachapelle. Head of Sales at CTOR. He was originally hired by $CTXR in April 2024 to be the Head of Sales. But he left in June 2025 to join YMAB. Looks like he is back with CTOR.
0 · Reply
TwongStocks
TwongStocks Feb. 2 at 3:21 PM
Fiscal Q1 for $CTXR and $CTOR ended on Dec 31. 10-Q filing deadline is Monday Feb 16. Both CTXR and CTOR will have to file their respective 10-Qs within the next couple of weeks. Biggest item is Lymphir sales. CTOR reported that it launched in December. The upcoming 10-Q will report Lymphir's sales from launch through Dec 31. First full quarter of Lymphir sales (Jan-Mar 2026) will not be reported until the May 10-Q. Other items to look for: • Cash on hand as of Dec 31 and updated runway for both companies. In the Dec 10-K, both companies reported a runway through March 2026. • Will there be any updates on Mino-Lok or Halo-Lido? • Will they issue any 2026 guidance for Lymphir sales?
5 · Reply
TwongStocks
TwongStocks Jan. 29 at 10:01 PM
$CTOR Definitive notice of shareholder consent filed. https://www.sec.gov/Archives/edgar/data/1851484/000121390026009524/ea0274187-def14c_citius.htm No major changes to the preliminary filing from Jan 20, which is explained in the quoted post. The approval of the warrants becomes effective February 18.
0 · Reply
kman1
kman1 Jan. 29 at 8:22 PM
$CTOR strange as he'll. Stock is running and no one says anything. This is rare as hens teeth.
0 · Reply
SweStonk
SweStonk Jan. 28 at 3:20 PM
$CTOR would be interesting to know how many over at $CTXR after being down 98%, bought Mazurs crap once again and invested in CTOR And if you did, how much are you down in CTOR? 50%?, 70%? Only one making money from CTXR and CTOR are Mazur and the shorts who are paying him heavily straight to his cayman account. Pssst, I have $5M to donate to charity but I dont have $5M or less to double down on the 98% loss on my 1 billion drug. Even tho you try to sell this shit to others? We all know if the pipeline was as you say it is you would have added on your position in a heart beat. But you and no one else in the management are and havent for YEARS because you know the scam will eventually crack...
1 · Reply
whathappenedtomyaccount
whathappenedtomyaccount Jan. 27 at 3:47 PM
$CTOR didn't they say they had manufactured stock on the shelves? what's the shelf life of that? is it just going to waste?
0 · Reply
SweStonk
SweStonk Jan. 23 at 10:49 PM
$CTOR You clearly dont know how to read. Argumenting with you is like talking to a wall. Go read business update from CTXR(parent company) and you will see they need more funding to commercialize lymphir and why Mazur is getting sued over his launch PR and later change to needing additional funding to commercialize. This is from the companies own business update. You should go read up before even thinking of making comments on a stock forum. You have facebook for the other stuff.... ML = dead Halo = dead Lymphir = not enough money and third in line treatment with better treatments making less than 100m/y(Lymphir with the debt = dead)
0 · Reply
NYC100
NYC100 Jan. 23 at 10:38 PM
$CTOR you getting mad because of the truth 😂😂
1 · Reply
SweStonk
SweStonk Jan. 23 at 10:27 PM
$CTOR People like him is why Mazur can continue his scam. News headline is enough of DD to invest into a company... You should just hand me your money. Your portfolio will be gone within a year anyway.
0 · Reply
NYC100
NYC100 Jan. 23 at 10:08 PM
$CTOR in the market and making money 💰 😂😂
1 · Reply
SweStonk
SweStonk Jan. 23 at 8:27 PM
$CTOR It is not an article but screenshot from CTXRs own business update released 23 december 2025 which you would understand if you actually read through it. Your DD seem to be some easy chatGPT prompts that go through news headlines and conclude information based on that alone. Goodluck investing in news headlines alone. That will really take you far 😂
0 · Reply
NYC100
NYC100 Jan. 23 at 8:10 PM
$CTOR the article you put does not even have the name of the company does not even mention the stock 😂😂
0 · Reply
SweStonk
SweStonk Jan. 23 at 6:42 PM
$CTOR every research? Go read the business update released 23 dec..... Why do you think SP crashed after it?
0 · Reply
NYC100
NYC100 Jan. 23 at 6:40 PM
$CTOR every research I did shows the same thing. Not sure why you’re lying. 
0 · Reply
SweStonk
SweStonk Jan. 23 at 5:58 PM
$CTOR U put that into ChatGPT which reads the PR from the company which say they launched lymphir. They lied with that PR because everything from A -> B(patients) isnt finished and in the business update you can clearly read that they need substantial funding for the launch. They PRd that they launched lymphir BUT u cannot launch anything if you dont have money for it which they say/provide in the business update 23 december. Tell ChatGPT to gp through the business update instead and not only the PR from the business.
0 · Reply
NYC100
NYC100 Jan. 23 at 5:11 PM
0 · Reply
SweStonk
SweStonk Jan. 23 at 5:02 PM
$CTOR people still believe lymphir is launched and available. Even tho they clearly stated in their business update We need additional substantial funding to launch lymphir. They lied about launch because they knew company wouldnt survive another delay so they lied.....
0 · Reply
donein12
donein12 Jan. 21 at 8:49 PM
$CTOR All of a sudden, there is buying demand for CTOR?
0 · Reply
TwongStocks
TwongStocks Jan. 20 at 10:06 PM
$CTOR Notice of action by stockholder consent https://www.sec.gov/Archives/edgar/data/1851484/000121390026005689/ea0273118-pre14c_citius.htm In Dec, CTOR issued 1,284,404 shares, 15,229,358 pre-funded warrants, & 16,513,762 common warrants. The pre-funded warrants were exercisable immediately. The common warrants need shareholder approval before they could be exercised. Since CTXR owns 66m shares, no shareholder vote will be necessary. As majority shareholder, CTXR gives their written consent to allow the common warrants to be exercised. Even if everyone else votes NO, the proposal would still pass. This is a preliminary notice of the shareholder consent. A definitive filing will follow. They now report that as of Jan 20, CTOR has 88,275,204 shares outstanding. This is an increase of approx 3.5m shares from the 84,797,846 shares they reported in their December 10-K. I assume some of the pre-funded warrants were exercised by Armistice. Speaking of Armistice, they did not list Armistice as a 5% owner as of Jan 20 👇
3 · Reply
whathappenedtomyaccount
whathappenedtomyaccount Jan. 20 at 7:21 PM
$CTOR will we ever see any sales figures for this wonder drug?
1 · Reply
SKEETER_1
SKEETER_1 Jan. 20 at 6:54 PM
$CTOR ive lost money to two ponzi schemes in my life so far. QaudrigaCX and $CTOR $CTXR. Wonder what my next one will be
1 · Reply
BillionerOfKing
BillionerOfKing Jan. 20 at 3:10 PM
$CTOR Current Stock Price: $1.01
0 · Reply